Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong ...

The company is “especially excited” about an immune cell therapy manufacturing technology included in the deal, a Merck KGaA executive said. Merck KGaA has agreed to buy Bio-Techne for $11.3 billion ...

A Merck KGaA, Darmstadt, Germany, researcher at work. Merck KGaA has agreed to acquire Bio-Techne for approximately $11.3 billion, in a deal designed to position the buyer as more of a leader across ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

Germany’s Merck MRK0.07%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH 0.21%increase; up pointing triangle for $11.3 billion, in an ...

Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...

German drugmaker Merck said on Thursday it will acquire U.S. biotech firm Bio-Techne Corp for US$11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

German pharmaceutical company Merck KGaA to purchase Bio-Techne in $11.3 billion transaction Acquisition price set at $73 per share, representing a 24% premium over Wednesday’s close Bio-Techne shares ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal represents a 36% ...

The acquisition marks the first under the watch of new CEO Kai Beckmann, who took the helm in September 2025. Credit: Kittyfly/Shutterstock.com. Merck KGaA has agreed to acquire life sciences company ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...